Ion channels and demyelination: Basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers;Canaux ioniques et démyélinisation: Les fondements d'un traitement de l'encéphalomyélite autoimmune expérimentale (EAE) par des bloqueurs des canaux potassium

Revue Neurologique

Volumn 160, Issue 5 II, 2004, Pages

  Devaux, J ^a,b   Beeton, C ^a,c   Beraud E ^a   Crest, M ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

EAE; Multiple sclerosis; Potassium channels; Scorpion toxin

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; DENDROTOXIN; ION CHANNEL; KALIOTOXIN; LYSOPHOSPHATIDYLCHOLINE; MYELIN BASIC PROTEIN; POTASSIUM CHANNEL BLOCKING AGENT; VOLTAGE GATED POTASSIUM CHANNEL; CALCIUM; CYTOKINE; DENDROTOXIN I; NEUROTOXIN; SCORPION VENOM; SNAKE VENOM;

ACTION POTENTIAL; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; CALCIUM TRANSPORT; CELL INFILTRATION; CELL MEMBRANE DEPOLARIZATION; CHANNEL GATING; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; EVOKED SOMATOSENSORY RESPONSE; IMMUNOCYTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; NERVE CELL EXCITABILITY; NERVE CONDUCTION; NONHUMAN; PARALYSIS; POTASSIUM TRANSPORT; RAT; REPOLARIZATION; T LYMPHOCYTE ACTIVATION; ADOPTIVE TRANSFER; AGING; ANIMAL; ARTICLE; DEMYELINATING DISEASE; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MYELIN SHEATH; NEWBORN; OPTIC NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE; WISTAR RAT;

ACTION POTENTIALS; ADOPTIVE TRANSFER; AGING; ANIMALS; ANIMALS, NEWBORN; CALCIUM; CYTOKINES; DEMYELINATING DISEASES; ELAPID VENOMS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ION CHANNEL GATING; ION CHANNELS; LYMPHOCYTE ACTIVATION; MYELIN BASIC PROTEINS; MYELIN SHEATH; NEURAL CONDUCTION; NEUROTOXINS; OPTIC NERVE; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; SCORPION VENOMS; T-LYMPHOCYTES;

EID: 4344685497     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. BEETON C, WULFF H, BARBARIA J et al. (2001a). Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci (USA), 24: 13942-13947.
2. + channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol, 166: 936-944.
3. BOIKO T, RASBAND MN, LEVINSON SR et al. (2001). Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron, 30: 91-104.
4. BOSTOCK H, SEARS TA, SHERRATT RM. (1981). The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres. J Physiol, 313: 301-315.
5. CAHALAN MD, WULFF H, CHANDY KG. (2001). Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol, 21: 235-352.
6. + channels characterized from Androctonus mauretanicus mauretanicus venom. J Biol Chem, 267: 1640-1647.
7. + channels. J Neurophysiol, 87: 1376-1385.
8. DEVAUX J, ALCARAZ G, GRINSPAN J et al. (2003a). Kv3.1b is a novel component of CNS nodes. J Neuroscience, 23: 4509-4518.
9. DEVAUX J, FORNI C, BEETON C et al. (2003b). Myelin basic protein-reactive T cells induce conduction failure in vivo but not in vitro. Neuroreport, 14: 1-4.
10. ENG DL, GORDON TR, KOCSIS JD, WAXMAN SG. (1988). Development of 4-AP and TEA sensitivities in mammalian myelinated nerve fibers. J Neurophysiol, 60: 2168-2179.
11. GRIJALVA I, GUIZAR-SAHAGUN G, CASTANEDA-HERNANDEZ G et al. (2003). Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial. Pharmacotherapy, 23: 823-834.
12. + channel gene. Proc Natl Acad Sci (USA), 87: 9411-9415.
13. JENKINS SM, BENNETT V. (2001). Ankyrin-G coordinates assembly of the spectrin-based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at Purkinje neuron initial segments. J Cell Biol, 155: 739-746.
14. JENSEN JM, SHI R. (2003). Effects of 4-Aminopyridine on Stretched Mammalian Spinal Cord: The Role of Potassium Channels in Axonal Conduction. J Neurophysiol, 90: 2334-2340.
15. KAPLAN MR, CHO MH, ULLIAN EM, ISOM LL, LEVINSON SR, BARRES BA. (2001). Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier. Neuron, 30: 105-119.
16. KHANNA A, LI B, STENZEL KH, SUTHANTHIRAN M. (1994). Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor β-dependent mechanism of inhibition of cell growth. Transplantation, 57: 577-582.
17. KRAMER SM, CARVER ME. (1986). Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol, Methods, 93: 201-206.
18. LIN CS, BOLTZ RC, BLAKE JT et al. (1993). Voltage gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med, 177: 637-645.
19. LOGSDON NJ, KANG J, TOGO JA, CHRISTIAN EP, AIYAR J. (1997). A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J Biol Chem, 272: 32723-32726.
20. MENEGOZ M, GASPAR P, LE BERT M et al. (1997). Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron, 19: 319-331.
21. + channel distribution and clustering in developing and hypomyelinated axons of the optic nerve. J Neurocytol, 28: 319-331.
22. SOLARI A, UITDEHAAG B, GIULIANI G, PUCCI E, TAUS C. (2003). Aminopyridines for symptomatic treatment in multiple sclerosis. Cochrane Database Syst Rev, 2: CD001330.
23. SMITH KJ, FELTS PA, JOHN GR. (2000). Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension. Brain, 123: 171-184.
24. WULFF H, CALABRESI PA, ALLIE R et al. (2003). The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest, 111: 1703-1713.